BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8093038)

  • 41. Molecular modeling of the interaction of polyproline-based peptides with the Abl-SH3 domain: rational modification of the interaction.
    Pisabarro MT; Ortiz AR; Viguera AR; Gago F; Serrano L
    Protein Eng; 1994 Dec; 7(12):1455-62. PubMed ID: 7716156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitotic phosphorylation rescues Abl from F-actin-mediated inhibition.
    Woodring PJ; Hunter T; Wang JY
    J Biol Chem; 2005 Mar; 280(11):10318-25. PubMed ID: 15632178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding site.
    Yang J; Campobasso N; Biju MP; Fisher K; Pan XQ; Cottom J; Galbraith S; Ho T; Zhang H; Hong X; Ward P; Hofmann G; Siegfried B; Zappacosta F; Washio Y; Cao P; Qu J; Bertrand S; Wang DY; Head MS; Li H; Moores S; Lai Z; Johanson K; Burton G; Erickson-Miller C; Simpson G; Tummino P; Copeland RA; Oliff A
    Chem Biol; 2011 Feb; 18(2):177-86. PubMed ID: 21338916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein.
    Zhu J; Shore SK
    Mol Cell Biol; 1996 Dec; 16(12):7054-62. PubMed ID: 8943360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation.
    Jiang T; Qiu Y
    J Biol Chem; 2003 May; 278(18):15789-93. PubMed ID: 12600984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The primary structure of a human MAP kinase activated protein kinase 2.
    Zu YL; Wu F; Gilchrist A; Ai Y; Labadia ME; Huang CK
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1118-24. PubMed ID: 8179591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thermodynamic dissection of the binding energetics of proline-rich peptides to the Abl-SH3 domain: implications for rational ligand design.
    Palencia A; Cobos ES; Mateo PL; Martínez JC; Luque I
    J Mol Biol; 2004 Feb; 336(2):527-37. PubMed ID: 14757063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CR16, a novel proline-rich protein expressed in rat brain neurons, binds to SH3 domains and is a MAP kinase substrate.
    Weiler MC; Smith JL; Masters JN
    J Mol Neurosci; 1996; 7(3):203-15. PubMed ID: 8906616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes.
    Agami R; Shaul Y
    Oncogene; 1998 Apr; 16(14):1779-88. PubMed ID: 9583676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2.
    Ben-Levy R; Leighton IA; Doza YN; Attwood P; Morrice N; Marshall CJ; Cohen P
    EMBO J; 1995 Dec; 14(23):5920-30. PubMed ID: 8846784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of extracellular signal-regulated kinase 2 by a novel Abl-binding protein, ST5.
    Majidi M; Hubbs AE; Lichy JH
    J Biol Chem; 1998 Jun; 273(26):16608-14. PubMed ID: 9632734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metallofullerenol Gd@C₈₂(OH)₂₂ distracts the proline-rich-motif from putative binding on the SH3 domain.
    Kang SG; Huynh T; Zhou R
    Nanoscale; 2013 Apr; 5(7):2703-12. PubMed ID: 23423582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoinhibition of mixed lineage kinase 3 through its Src homology 3 domain.
    Zhang H; Gallo KA
    J Biol Chem; 2001 Dec; 276(49):45598-603. PubMed ID: 11590155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural basis for the binding of proline-rich peptides to SH3 domains.
    Yu H; Chen JK; Feng S; Dalgarno DC; Brauer AW; Schreiber SL
    Cell; 1994 Mar; 76(5):933-45. PubMed ID: 7510218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function.
    Grover P; Shi H; Baumgartner M; Camacho CJ; Smithgall TE
    PLoS One; 2015; 10(7):e0133590. PubMed ID: 26222440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A binding event converted into a folding event.
    Martín-Sierra FM; Candel AM; Casares S; Filimonov VV; Martínez JC; Conejero-Lara F
    FEBS Lett; 2003 Oct; 553(3):328-32. PubMed ID: 14572645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of Ser/Pro-rich domain and kinase domain of double cortin-like protein kinase on microtubule-binding activity.
    Nagamine T; Shimomura S; Sueyoshi N; Kameshita I
    J Biochem; 2011 May; 149(5):619-27. PubMed ID: 21278387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple Src Homology 3 Binding to the Ubiquitin Ligase Itch Conserved Proline-Rich Region.
    Desrochers G; Lussier-Price M; Omichinski JG; Angers A
    Biochemistry; 2015 Dec; 54(50):7345-54. PubMed ID: 26613292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils.
    Huang CK; Zhan L; Ai Y; Jongstra J
    J Biol Chem; 1997 Jan; 272(1):17-9. PubMed ID: 8995217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response.
    Cao C; Leng Y; Li C; Kufe D
    J Biol Chem; 2003 Apr; 278(15):12961-7. PubMed ID: 12569093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.